Botulinum antitoxin

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J06AA04 Botulinum antitoxin J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06A Immune sera → J06AA Immune sera
Discover more medicines within J06AA04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
BABYBIG Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

External identifiers

DrugBank Drug: DB14115
RxNorm Ingredient: 544488
SNOMED-CT Concept: 385336006
Botulinum antitoxin (substance)
UNII Identifier: X641Y30OA7
HUMAN BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN

Medicines

Botulinum antitoxin is an active ingredient of these brands:

United States (US)

  • BABYBIG
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2
  • (combination) BAT as EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈